Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$3.6 - $7.15 $1.82 Million - $3.62 Million
-506,895 Reduced 94.05%
32,091 $225,000
Q3 2023

Nov 13, 2023

BUY
$4.79 - $7.19 $1.91 Million - $2.87 Million
398,986 Added 284.99%
538,986 $2.65 Million
Q3 2023

Nov 09, 2023

SELL
$4.79 - $7.19 $1.91 Million - $2.87 Million
-398,986 Reduced 74.03%
140,000 $687,000
Q1 2023

May 11, 2023

SELL
$5.04 - $8.6 $80,861 - $137,978
-16,044 Reduced 2.89%
538,986 $2.79 Million
Q3 2022

Nov 14, 2022

BUY
$7.55 - $11.25 $415,476 - $619,087
55,030 Added 11.01%
555,030 $4.04 Million
Q1 2022

May 13, 2022

BUY
$13.42 - $23.38 $671,000 - $1.17 Million
50,000 Added 11.11%
500,000 $6.93 Million
Q4 2020

Jan 19, 2021

BUY
$12.4 - $17.6 $930,000 - $1.32 Million
75,000 Added 20.0%
450,000 $6.81 Million
Q3 2020

Oct 13, 2020

BUY
$11.59 - $14.93 $869,250 - $1.12 Million
75,000 Added 25.0%
375,000 $4.97 Million
Q2 2020

Jul 16, 2020

BUY
$11.79 - $15.97 $633,040 - $857,477
53,693 Added 21.8%
300,000 $3.76 Million
Q1 2020

Apr 16, 2020

BUY
$9.31 - $21.24 $512,115 - $1.17 Million
55,007 Added 28.75%
246,307 $3.31 Million
Q4 2019

Jan 17, 2020

BUY
$13.91 - $21.48 $2.66 Million - $4.11 Million
191,300 New
191,300 $3.83 Million

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $292M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Rhenman & Partners Asset Management Ab Portfolio

Follow Rhenman & Partners Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.